Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Dec;93(3):315-8.
doi: 10.1016/j.yexmp.2012.10.013. Epub 2012 Oct 23.

Host response in tumor diagnosis and prognosis: importance of immunologists and pathologists alliance

Olivera J Finn  1
Affiliations
Review

Host response in tumor diagnosis and prognosis: importance of immunologists and pathologists alliance

Olivera J Finn. Exp Mol Pathol. 2012 Dec.

Abstract

Pathologists and immunologists have collaborated over many years in their efforts to understand and properly diagnose cancer. The ability of pathologists to correctly diagnose this disease was facilitated by the development of immunohistology that utilized specificity of antibodies to distinguish between normal cells and cancer cells. Further boost was provided through the advent of monoclonal antibodies. The two disciplines are now together on the brink of a paradigm shift resulting from a better understanding of the importance for cancer diagnosis and prognosis to consider not only the characteristics of the cancer cells, but also the cancer microenvironment reflecting the host response to the disease. This new immunology and pathology alliance named "Immunoscore" will advance research in both disciplines as well as benefit patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Immunohistology of primary colon tumors in a tissue microarray (TMA) showing examples of tumors with low (A and C) and high (B and D) CD8 T cell infiltration. Tumor is stained blue (cytokeratin) and CD8+ T cells brown. Images are courtesy of Dr. Jerome Galon.
Figure 1
Figure 1
Immunohistology of primary colon tumors in a tissue microarray (TMA) showing examples of tumors with low (A and C) and high (B and D) CD8 T cell infiltration. Tumor is stained blue (cytokeratin) and CD8+ T cells brown. Images are courtesy of Dr. Jerome Galon.
Figure 1
Figure 1
Immunohistology of primary colon tumors in a tissue microarray (TMA) showing examples of tumors with low (A and C) and high (B and D) CD8 T cell infiltration. Tumor is stained blue (cytokeratin) and CD8+ T cells brown. Images are courtesy of Dr. Jerome Galon.
Figure 1
Figure 1
Immunohistology of primary colon tumors in a tissue microarray (TMA) showing examples of tumors with low (A and C) and high (B and D) CD8 T cell infiltration. Tumor is stained blue (cytokeratin) and CD8+ T cells brown. Images are courtesy of Dr. Jerome Galon.
See this image and copyright information in PMC

Similar articles

  • A study of the immune infiltrate and patient outcomes in esophageal cancer.
    Conroy MJ, Kennedy SA, Doyle SL, Hayes B, Kavanagh M, van der Stok EP, O'Sullivan K, Cathcart MC, Reynolds JV, Lysaght J. Conroy MJ, et al. Carcinogenesis. 2021 Apr 17;42(3):395-404. doi: 10.1093/carcin/bgaa101. Carcinogenesis. 2021. PMID: 32940666
  • Molecular profile reveals immune-associated markers of lymphatic invasion in human colon adenocarcinoma.
    Shi J, Jiang D, Yang S, Sun Y, Wang J, Zhang X, Liu Y, Lu Y, Yang K. Shi J, et al. Int Immunopharmacol. 2020 Jun;83:106402. doi: 10.1016/j.intimp.2020.106402. Epub 2020 Mar 19. Int Immunopharmacol. 2020. PMID: 32200154
  • International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study.
    Pagès F, Mlecnik B, Marliot F, Bindea G, Ou FS, Bifulco C, Lugli A, Zlobec I, Rau TT, Berger MD, Nagtegaal ID, Vink-Börger E, Hartmann A, Geppert C, Kolwelter J, Merkel S, Grützmann R, Van den Eynde M, Jouret-Mourin A, Kartheuser A, Léonard D, Remue C, Wang JY, Bavi P, Roehrl MHA, Ohashi PS, Nguyen LT, Han S, MacGregor HL, Hafezi-Bakhtiari S, Wouters BG, Masucci GV, Andersson EK, Zavadova E, Vocka M, Spacek J, Petruzelka L, Konopasek B, Dundr P, Skalova H, Nemejcova K, Botti G, Tatangelo F, Delrio P, Ciliberto G, Maio M, Laghi L, Grizzi F, Fredriksen T, Buttard B, Angelova M, Vasaturo A, Maby P, Church SE, Angell HK, Lafontaine L, Bruni D, El Sissy C, Haicheur N, Kirilovsky A, Berger A, Lagorce C, Meyers JP, Paustian C, Feng Z, Ballesteros-Merino C, Dijkstra J, van de Water C, van Lent-van Vliet S, Knijn N, Mușină AM, Scripcariu DV, Popivanova B, Xu M, Fujita T, Hazama S, Suzuki N, Nagano H, Okuno K, Torigoe T, Sato N, Furuhata T, Takemasa I, Itoh K, Patel PS, Vora HH, Shah B, Patel JB, Rajvik KN, Pandya SJ, Shukla SN, Wang Y, Zhang G, Kawakami Y, Marincola FM, Ascierto PA, Sargent DJ, Fox BA, Galon J. Pagès F, et al. Lancet. 2018 May 26;391(10135):2128-2139. doi: 10.1016/S0140-6736(18)30789-X. Epub 2018 May 10. Lancet. 2018. PMID: 29754777
  • [Approved monoclonal antibodies for in vivo diagnosis].
    Schäffner G, Kabelitz D. Schäffner G, et al. Dtsch Med Wochenschr. 2001 Jul 13;126(28-29):819-22. doi: 10.1055/s-2001-15697. Dtsch Med Wochenschr. 2001. PMID: 11499265 Review. German. No abstract available.
  • Importance of MUC1 and spontaneous mouse tumor models for understanding the immunobiology of human adenocarcinomas.
    Finn OJ, Gantt KR, Lepisto AJ, Pejawar-Gaddy S, Xue J, Beatty PL. Finn OJ, et al. Immunol Res. 2011 Aug;50(2-3):261-8. doi: 10.1007/s12026-011-8214-1. Immunol Res. 2011. PMID: 21717081 Review.
See all similar articles

Cited by

References

    1. Arul GS, et al. Mucin gene expression in Barrett’s oesophagus: an in situ hybridisation and immunohistochemical study. Gut. 2000;47:753–61. - PMC - PubMed
    1. Baldus SE, et al. Comparative evaluation of the prognostic value of MUC1, MUC2, sialyl-Lewis(a) and sialyl-Lewis(x) antigens in colorectal adenocarcinoma. Histopathology. 2002;40:440–9. - PubMed
    1. Barnd DL, et al. Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells. Proc Natl Acad Sci U S A. 1989;86:7159–63. - PMC - PubMed
    1. Brockhausen I, et al. Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells. Eur J Biochem. 1995;233:607–17. - PubMed
    1. Burchell JM, et al. O-linked glycosylation in the mammary gland: changes that occur during malignancy. J Mammary Gland Biol Neoplasia. 2001;6:355–64. - PubMed